Literature DB >> 9134037

Liver histopathology in patients with concurrent chronic hepatitis C and HIV infection.

E Bierhoff1, H P Fischer, E Willsch, J Rockstroh, U Spengler, H H Brackmann, J Oldenburg.   

Abstract

To investigate the influence of human immunodeficiency virus (HIV) coinfection on preexisting long-term chronic C hepatitis (HCV) 68 liver biopsies from 22 HIV/HCV-coinfected, 13 HIV- and 33 HCV-monoinfected patients and 71 livers obtained at autopsy from 26 HIV/HCV-coinfected and 45 HIV-monoinfected patients were studied by histo- and immunohistochemistry. All HIV patients had reached the advanced stage of immunodeficiency (stage III CDC), except for 3 haemophilias (stage II CDC). HCV infection was associated with a higher degree of portal, periportal and lobular inflammation-regardless of whether there was concurrent HIV infection. HIV/HCV coinfection was associated with a significantly higher rate of granulocytic cholangiolitis than HCV and HIV monoinfection (P < 0.05), a histological feature uncommon in C hepatitis. In HIV/HCV coinfection cholestasis was a predominant histological feature. HCV monoinfection and HCV/HIV coinfection were associated with the highest fibrosis index. In HIV/HCV coinfection centrilobular fibrosis was significantly more marked than in HCV monoinfection (P < 0.05), suggesting an HIV-associated fibrogenic effect. Patients with chronic C hepatitis showed a significantly increased rate of posthepatitic cirrhosis compared with the patients without HCV infection (P < 0.05). At autopsy, 10 of the 20 HIV/HCV-coinfected haemophiliacs had developed cirrhosis because of chronic C hepatitis, whereas cirrhosis was found in only 2 of 6 HIV/HCV-coinfected non-haemophiliacs (1 case of chronic B and C hepatitis, and 1 case of chronic alcohol abuse). No cirrhosis was observed in the 45 autopsy patients with HIV monoinfection. The findings suggest that HIV coinfection aggravates the course of preceding long-term chronic C hepatitis by a more marked (centrilobular) fibrosis. HIV/HCV-coinfected patients are threatened by a higher rate of posthepatitic cirrhosis-particularly in multitransfused haemophiliacs-and cholestatic hepatopathy.

Entities:  

Mesh:

Year:  1997        PMID: 9134037     DOI: 10.1007/bf01092749

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  37 in total

1.  The pathology of hepatitis C.

Authors:  P J Scheuer; P Ashrafzadeh; S Sherlock; D Brown; G M Dusheiko
Journal:  Hepatology       Date:  1992-04       Impact factor: 17.425

2.  The effect of concurrent human immunodeficiency virus infection on chronic hepatitis B: a study of 150 homosexual men.

Authors:  N Bodsworth; B Donovan; B N Nightingale
Journal:  J Infect Dis       Date:  1989-10       Impact factor: 5.226

3.  Histologic observations in human hepatitis non-A, non-B.

Authors:  H P Dienes; H Popper; W Arnold; H Lobeck
Journal:  Hepatology       Date:  1982 Sep-Oct       Impact factor: 17.425

4.  Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.

Authors:  H J Alter; R H Purcell; J W Shih; J C Melpolder; M Houghton; Q L Choo; G Kuo
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

5.  Prevalence of antibodies to hepatitis C virus (HCV) in haemophiliacs.

Authors:  W Schramm; M Roggendorf; F Rommel; R Kammerer; H Pohlmann; R Rasshofer; L Gürtler; F Deinhardt
Journal:  Blut       Date:  1989-10

6.  Cholestatic hepatitis leading to hepatic failure in a patient with organ-transmitted hepatitis C virus infection.

Authors:  H L Lim; G K Lau; G L Davis; D J Dolson; J Y Lau
Journal:  Gastroenterology       Date:  1994-01       Impact factor: 22.682

7.  The intraportal lymphoid nodule and its environment in chronic active hepatitis C: an immunohistochemical study.

Authors:  J F Mosnier; C Degott; P Marcellin; D Hénin; S Erlinger; J P Benhamou
Journal:  Hepatology       Date:  1993-03       Impact factor: 17.425

Review 8.  Histopathologic findings in chronic hepatitis C.

Authors:  H P Fischer; E Willsch; E Bierhoff; U Pfeifer
Journal:  J Hepatol       Date:  1996       Impact factor: 25.083

9.  The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team.

Authors:  M J Alter; H S Margolis; K Krawczynski; F N Judson; A Mares; W J Alexander; P Y Hu; J K Miller; M A Gerber; R E Sampliner
Journal:  N Engl J Med       Date:  1992-12-31       Impact factor: 91.245

10.  The influence of HTLV-III infection on the natural history of hepatitis B virus infection in male homosexual HBsAg carriers.

Authors:  K Krogsgaard; B O Lindhardt; J O Nielson; P Andersson; P Kryger; J Aldershvile; J Gerstoft; C Pedersen
Journal:  Hepatology       Date:  1987 Jan-Feb       Impact factor: 17.425

View more
  11 in total

1.  HIV-HCV Coinfection.

Authors:  Amrita Sethi; Richard K Sterling
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-05

2.  Comparison of hepatitis C viral loads in patients with or without human immunodeficiency virus.

Authors:  J M Matthews-Greer; G C Caldito; S D Adley; R Willis; A C Mire; R M Jamison; K L McRae; J W King; W L Chang
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

3.  Hepatitis C and HIV-1 coinfection.

Authors:  A H Mohsen; P Easterbrook; C B Taylor; S Norris
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

4.  Characteristics of hepatitis C virus infection in HIV-infected people.

Authors:  C L Cooper; A D Badley; J B Angel
Journal:  Can J Infect Dis       Date:  2001-05

Review 5.  Management of chronic hepatitis C in patients co-infected with HIV: focus on safety considerations.

Authors:  Miriam Romero; Mayte Pérez-Olmeda; Javier García-Samaniego; Vicente Soriano
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

6.  Hematologic toxicity associated with interferon-based hepatitis C therapy in HIV type 1-coinfected subjects.

Authors:  Caroline M Behler; Eric Vittinghoff; Feng Lin; Raymond T Chung; Marion G Peters; Gregory K Robbins; Paul A Volberding
Journal:  Clin Infect Dis       Date:  2007-04-12       Impact factor: 9.079

Review 7.  Challenges in the management of HIV and hepatitis C virus co-infection.

Authors:  Winston Lee; Douglas Dieterich
Journal:  Drugs       Date:  2004       Impact factor: 9.546

8.  Impact of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis.

Authors:  Li-Ping Deng; Xi-En Gui; Yong-Xi Zhang; Shi-Cheng Gao; Rong-Rong Yang
Journal:  World J Gastroenterol       Date:  2009-02-28       Impact factor: 5.742

9.  HIV and Hepatitis Virus Infection.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-04       Impact factor: 3.663

10.  Selected biochemical and hematological abnormalities in Nigerians with human immunodeficiency virus and hepatitis C virus coinfection.

Authors:  Olive Obienu; Sylvester Nwokediuko
Journal:  Hepat Med       Date:  2011-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.